MMP-9 and fibronectin are both highly expressed in the breast cancer TME; Therefore, our imaging and therapeutic strategy can enable real-time detection of 4T1 breast primary and micro-metastatic lesions and image-guided cancer surgery. The gene discussed is MMP9; the disease is breast carcinoma.